Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Carcinoma and CYP2B6[original query] |
---|
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. Pharmacogenetics and genomics 2013 Jun 23 (6): 293-300. D'Avolio Antonio, De Francia Silvia, Basile Vittoria, Cusato Jessica, De Martino Francesca, Pirro Elisa, Piccione Francesca, Ardito Arianna, Zaggia Barbara, Volante Marco, Di Perri Giovanni, Terzolo Massi |
Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma. Oncotarget 2016 May . Zhou Jun, Wen Qiang, Li Sai-Fei, Zhang Yun-Fei, Gao Na, Tian Xin, Fang Yan, Gao Jie, Cui Ming-Zhu, He Xiao-Pei, Jia Lin-Jing, Jin Han, Qiao Hai-Li |
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study. Cancers 2020 Feb 12 (2): . Altieri Barbara, Sbiera Silviu, Herterich Sabine, De Francia Silvia, Della Casa Silvia, Calabrese Anna, Pontecorvi Alfredo, Quinkler Marcus, Kienitz Tina, Mannelli Massimo, Canu Letizia, Angelousi Anna, Chortis Vasileios, Kroiss Matthias, Terzolo Massimo, Fassnacht Martin, Ronchi Cristina |
The Effects of Cumulative Dose and Polymorphisms in CYP2B6 on the Mitotane Plasma Trough Concentrations in Chinese Patients With Advanced Adrenocortical Carcinoma. Frontiers in oncology 2022 12 919027. Liu Xin, Shang Junmei, Fu Qiang, Lu Lin, Deng Jianhua, Tang Yan, Li Jiantao, Mei Dan, Zhang Bo, Zhang Shuya |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: